US Stock MarketDetailed Quotes

ZyVersa Therapeutics (ZVSA)

Watchlist
  • 0.2100
  • +0.0200+10.53%
15min DelayClose Apr 24 15:49 ET
1.02MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ZyVersa Therapeutics (ZVSA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-25.09%6.84M
-57.11%551.86K
-7.29%2.1M
-25.78%2.04M
-24.13%2.14M
-36.64%9.14M
-27.57%1.29M
-21.81%2.27M
-46.52%2.75M
-38.45%2.83M
Selling and administrative expenses
-22.10%5.73M
-59.44%472.62K
-5.15%1.74M
-20.09%1.63M
-18.50%1.89M
-34.38%7.36M
-23.29%1.17M
-17.73%1.83M
-47.96%2.04M
-34.57%2.31M
-General and administrative expense
-22.10%5.73M
-59.44%472.62K
-5.15%1.74M
-20.09%1.63M
-18.50%1.89M
-34.38%7.36M
-23.29%1.17M
-17.73%1.83M
-47.96%2.04M
-34.57%2.31M
Research and development costs
-37.44%1.11M
-34.64%79.24K
-16.28%365.05K
-42.18%409.94K
-49.53%258.88K
-44.53%1.78M
-52.84%121.25K
-35.30%436.04K
-41.91%709.05K
-51.42%512.94K
Operating profit
25.09%-6.84M
57.11%-551.86K
7.29%-2.1M
25.78%-2.04M
24.13%-2.14M
36.64%-9.14M
27.57%-1.29M
21.81%-2.27M
46.52%-2.75M
38.45%-2.83M
Net non-operating interest income expense
-90.18%-513.21K
4.20%-132.26K
0.22%-131.35K
-224,100.00%-130.04K
-118,275.25%-119.56K
-59,149.45%-269.86K
-140,779.59%-138.06K
-62,583.33%-131.64K
81.53%-58
-109.37%-101
Non-operating interest expense
90.18%513.21K
-4.20%132.26K
-0.22%131.35K
224,100.00%130.04K
118,275.25%119.56K
--269.86K
--138.06K
62,583.33%131.64K
--58
--101
Total other finance cost
----
----
----
----
----
59,149.45%269.86K
----
----
-81.53%58
----
Other net income (expense)
-18.45M
5.55K
-18.42M
-37.15K
7.2K
Special income (charges)
---18.65M
--0
---18.65M
----
----
--0
--0
--0
--0
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
--0
--0
--0
----
-Write off
--18.65M
--0
--18.65M
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
--201.86K
--5.55K
--226.26K
---37.15K
--7.2K
----
----
----
----
----
Income before tax
-174.32%-25.8M
52.37%-678.57K
-760.27%-20.66M
19.71%-2.21M
20.16%-2.26M
91.27%-9.41M
89.78%-1.42M
17.28%-2.4M
96.81%-2.75M
38.43%-2.83M
Income tax
-12,726.52%-851.66K
0
-851.66K
0
100.07%6.75K
99.50%-2.96K
0
100.12%9.71K
0
Net income
-165.07%-24.95M
52.27%-678.57K
-724.80%-19.81M
19.99%-2.21M
20.16%-2.26M
90.42%-9.41M
89.34%-1.42M
17.27%-2.4M
96.48%-2.76M
20.24%-2.83M
Net income continuous Operations
-165.07%-24.95M
52.27%-678.57K
-724.80%-19.81M
19.99%-2.21M
20.16%-2.26M
90.42%-9.41M
89.34%-1.42M
17.27%-2.4M
96.48%-2.76M
20.24%-2.83M
Minority interest income
Net income attributable to the parent company
-165.07%-24.95M
52.27%-678.57K
-724.80%-19.81M
19.99%-2.21M
20.16%-2.26M
90.42%-9.41M
89.34%-1.42M
17.27%-2.4M
96.48%-2.76M
20.24%-2.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-165.07%-24.95M
52.27%-678.57K
-724.80%-19.81M
19.99%-2.21M
20.16%-2.26M
91.14%-9.41M
89.34%-1.42M
18.18%-2.4M
96.80%-2.76M
20.24%-2.83M
Basic earnings per share
50.71%-4.18
179.39%0.45
-5.35%-2.56
86.10%-0.46
98.39%-0.73
99.22%-8.48
98.28%-0.5668
91.95%-2.43
99.80%-3.31
66.66%-45.3
Diluted earnings per share
50.71%-4.18
179.39%0.45
-5.35%-2.56
86.10%-0.46
98.39%-0.73
99.22%-8.48
98.28%-0.5668
91.95%-2.43
99.80%-3.31
66.66%-45.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -25.09%6.84M-57.11%551.86K-7.29%2.1M-25.78%2.04M-24.13%2.14M-36.64%9.14M-27.57%1.29M-21.81%2.27M-46.52%2.75M-38.45%2.83M
Selling and administrative expenses -22.10%5.73M-59.44%472.62K-5.15%1.74M-20.09%1.63M-18.50%1.89M-34.38%7.36M-23.29%1.17M-17.73%1.83M-47.96%2.04M-34.57%2.31M
-General and administrative expense -22.10%5.73M-59.44%472.62K-5.15%1.74M-20.09%1.63M-18.50%1.89M-34.38%7.36M-23.29%1.17M-17.73%1.83M-47.96%2.04M-34.57%2.31M
Research and development costs -37.44%1.11M-34.64%79.24K-16.28%365.05K-42.18%409.94K-49.53%258.88K-44.53%1.78M-52.84%121.25K-35.30%436.04K-41.91%709.05K-51.42%512.94K
Operating profit 25.09%-6.84M57.11%-551.86K7.29%-2.1M25.78%-2.04M24.13%-2.14M36.64%-9.14M27.57%-1.29M21.81%-2.27M46.52%-2.75M38.45%-2.83M
Net non-operating interest income expense -90.18%-513.21K4.20%-132.26K0.22%-131.35K-224,100.00%-130.04K-118,275.25%-119.56K-59,149.45%-269.86K-140,779.59%-138.06K-62,583.33%-131.64K81.53%-58-109.37%-101
Non-operating interest expense 90.18%513.21K-4.20%132.26K-0.22%131.35K224,100.00%130.04K118,275.25%119.56K--269.86K--138.06K62,583.33%131.64K--58--101
Total other finance cost --------------------59,149.45%269.86K---------81.53%58----
Other net income (expense) -18.45M5.55K-18.42M-37.15K7.2K
Special income (charges) ---18.65M--0---18.65M----------0--0--0--0----
-Less:Impairment of capital assets ----------------------0--0--0--0----
-Write off --18.65M--0--18.65M----------0--0--0--0----
Other non- operating income (expenses) --201.86K--5.55K--226.26K---37.15K--7.2K--------------------
Income before tax -174.32%-25.8M52.37%-678.57K-760.27%-20.66M19.71%-2.21M20.16%-2.26M91.27%-9.41M89.78%-1.42M17.28%-2.4M96.81%-2.75M38.43%-2.83M
Income tax -12,726.52%-851.66K0-851.66K0100.07%6.75K99.50%-2.96K0100.12%9.71K0
Net income -165.07%-24.95M52.27%-678.57K-724.80%-19.81M19.99%-2.21M20.16%-2.26M90.42%-9.41M89.34%-1.42M17.27%-2.4M96.48%-2.76M20.24%-2.83M
Net income continuous Operations -165.07%-24.95M52.27%-678.57K-724.80%-19.81M19.99%-2.21M20.16%-2.26M90.42%-9.41M89.34%-1.42M17.27%-2.4M96.48%-2.76M20.24%-2.83M
Minority interest income
Net income attributable to the parent company -165.07%-24.95M52.27%-678.57K-724.80%-19.81M19.99%-2.21M20.16%-2.26M90.42%-9.41M89.34%-1.42M17.27%-2.4M96.48%-2.76M20.24%-2.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -165.07%-24.95M52.27%-678.57K-724.80%-19.81M19.99%-2.21M20.16%-2.26M91.14%-9.41M89.34%-1.42M18.18%-2.4M96.80%-2.76M20.24%-2.83M
Basic earnings per share 50.71%-4.18179.39%0.45-5.35%-2.5686.10%-0.4698.39%-0.7399.22%-8.4898.28%-0.566891.95%-2.4399.80%-3.3166.66%-45.3
Diluted earnings per share 50.71%-4.18179.39%0.45-5.35%-2.5686.10%-0.4698.39%-0.7399.22%-8.4898.28%-0.566891.95%-2.4399.80%-3.3166.66%-45.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -